🇺🇸 FDA
Pipeline program

Autologous Tumor Infiltrating Lymphocytes MDA-TIL

2017-0671

Phase 2 mab terminated

Quick answer

Autologous Tumor Infiltrating Lymphocytes MDA-TIL for Malignant Solid Neoplasm is a Phase 2 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Malignant Solid Neoplasm
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials